BIOATLA INC (BCAB)

US09077B1044 - Common Stock

0.678  +0.06 (+10.42%)

After market: 0.678 0 (0%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
11.00M0.000.00250.00K430.00K
Minority Interest Expense
N/AN/AN/A0.000.00
Operating Expenses
97.23M129.69M108.14M96.69M30.53M
Research and Development
74.12M103.73M79.35M58.27M19.93M
Selling, General, and Administrative Expenses
23.12M25.96M28.79M38.42M10.60M
Operating Income
-86.23M-129.69M-108.14M-96.44M-30.10M
Interest Income/Expense
4.45M6.31M1.65M350.00K-2.87M
Other Income/Expense
-35.00K-87.00K10.00K0.000.00
Non Recurring Items
N/AN/A0.00690.00K-2.88M
Income Before Taxes
-81.82M-123.46M-106.48M-95.40M-35.85M
Net Income
-81.82M-123.46M-106.48M-95.40M-35.85M
EBITDA
-85.17M-128.47M-106.94M-95.11M-29.09M
 
Per Share Data
EPS Diluted Total Ops
-1.70-2.58-2.74-2.76-1.12
Non GAAP EPS
-1.70-2.59-2.74-2.76N/A
 
Statistics
Profit Margin
-743.79%N/AN/A-38160.00%-8337.21%
Operating Profit Margin
-783.95%N/AN/A-38576.00%-7000.00%

All data in USD

Charts